First of all, they can short all they want. The company is gonna make us rich.
Second of all, you complain but give no suggestions as to what to do. And please don't start with the buy back stuff. It doesn't happen in these little biotechs.
Lastly, if you don't like the company then sell but don't come here and whine.
He will sell the living hell out of this drug once approved. Company is primed and ready to move it.
Sellers think they smart by selling news. Rookies will wish they hadn't exited.
I agree. Remember we had two things happen which changed the scene for FOLD. First was the FDA asking for more info. Yes this is not a good thing but often it just pushes back the timeline for approval which makes impatient investors sell and look for fast returns. Then shortly after we had the biotech bloodbath and while this may sound a bit crazy, FOLD has held up as good if not better than most of its peers during the selling.
If you held ths long, you might as well stay for the duration and for the EU decision. I know I am and expect good news.
FOLD tends to open higher most everyday, only to sell down within the next hour or two.
IMO, if we hold today's open, the stock is once again off to the races.
It's not Crowley, it's Feuerstein. He's the one who wrote last month that s decision was coming at that time. It's up to him to confirm info like that.
Maybe I'm wrong but I'm still not concerned and FOLD.
You buy stocks like FOLD for big risk and big moves. 50/50 for a biotech is a pretty decent bet. Sure it's even odds but most bios are way bigger long shots.
I don't watch him anymore but I do believe that cramer has lost his mojo. As a matter of fact, we'd probably be up if he said to sell. He's great in a bull market...Just like everyone else.
I agree plus as I have said before, I am very confident that once Migalistat is approved in Europe, FOLD will beat earnings estimates, especially the first quarter of sales. Mr Crowley is connected with drs. and has a great sales force who are ready to move product.
Some here bashed me for supporting Mr. Crowley but now you are seeing his smart moves at work. You complained about insider selling but obviously, you don't understand biotech. All insiders in all biotechs sell when the stock goes up. Just do a little DD and you'll find that out. It's a risky proposition to have a big hunk of your net worth in these firms and any smart insider knows it, no matter how good trials may look.
Once we get more good news on the digestive questions with Migalistat, we will REALLY be off to the races once again.
Looks to me that the new data confirms just how well the drug works. The last missing piece of the puzzle is the issue of diarrhea that the FDA asked about. If it was in this study and was positive, we'd be up 2 bucks or more. In time.
I agree. It's a shame that biotechs are so in the dumper right now because in even a decent market, this type of news which confirms the efficacy of Migalastat would make the stock fly and while I would like that to happen, I can wait a year or so for the big sales out of Europe to begin.